| | | Single nucleotide variant (intron variant) | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA +5 more | |
| | | Single nucleotide variant (missense variant) | Multiple endocrine neoplasia, type 2 +7 more | |
| | | Single nucleotide variant (missense variant) | Pheochromocytoma +8 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +7 more | |
| | | Single nucleotide variant (missense variant) | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +1 more) | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA +4 more | |
| | | Single nucleotide variant (synonymous variant) | Multiple endocrine neoplasia, type 2 +6 more | |
| | | Single nucleotide variant (missense variant) | not provided +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Pheochromocytoma +7 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | RET-related condition +8 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +6 more | |
| | | Single nucleotide variant (missense variant) | Familial medullary thyroid carcinoma +8 more | |
| | | Single nucleotide variant (missense variant) | not provided +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Multiple endocrine neoplasia, type 2 +7 more | |
| | | Single nucleotide variant (missense variant) | Thyroid gland carcinoma +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | not provided +5 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | |
| | | Single nucleotide variant (missense variant) | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA +7 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +7 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA +7 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Familial medullary thyroid carcinoma +8 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | RET-related condition +10 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hirschsprung disease, susceptibility to, 1 +6 more | |
| | | Single nucleotide variant (missense variant) | Multiple endocrine neoplasia, type 2 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | not provided +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | RET-related condition +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Familial medullary thyroid carcinoma +8 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not specified +9 more | |
| | | Single nucleotide variant (intron variant) | Pheochromocytoma +7 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Multiple endocrine neoplasia, type 2 +6 more | |
| | | Single nucleotide variant (synonymous variant) | RET-related condition +4 more | |
| | | Single nucleotide variant (missense variant) | MEN2 phenotype: Unclassified +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | MEN2 phenotype: Unclassified +13 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Multiple endocrine neoplasia, type 2 +5 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +7 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +8 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +7 more | |
| | | Single nucleotide variant (missense variant) | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB +3 more | |
| | | Single nucleotide variant (missense variant) | not provided +7 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | RET-related condition +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +9 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +4 more | |
| | | Single nucleotide variant (missense variant) | not provided +10 more | |
| | | Single nucleotide variant (synonymous variant) | Multiple endocrine neoplasia, type 2 +6 more | |
| | | Single nucleotide variant (missense variant) | Familial medullary thyroid carcinoma +17 more | GPathogenic/Likely pathogenic |